BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23423351)

  • 1. Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer.
    Ramakrishnan R; Gabrilovich DI
    Cancer Immunol Immunother; 2013 Mar; 62(3):405-10. PubMed ID: 23423351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer.
    Ramakrishnan R; Gabrilovich DI
    Cancer Immunol Immunother; 2011 Mar; 60(3):419-23. PubMed ID: 20976448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoimmunotherapy.
    Emens LA
    Cancer J; 2010; 16(4):295-303. PubMed ID: 20693839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy.
    Ramakrishnan R; Huang C; Cho HI; Lloyd M; Johnson J; Ren X; Altiok S; Sullivan D; Weber J; Celis E; Gabrilovich DI
    Cancer Res; 2012 Nov; 72(21):5483-93. PubMed ID: 22942258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving synergistic combinations of targeted immunotherapies to combat cancer.
    Melero I; Berman DM; Aznar MA; Korman AJ; Pérez Gracia JL; Haanen J
    Nat Rev Cancer; 2015 Aug; 15(8):457-72. PubMed ID: 26205340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy.
    Nars MS; Kaneno R
    Int J Cancer; 2013 Jun; 132(11):2471-8. PubMed ID: 22927096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined modality immunotherapy and chemotherapy: a new perspective.
    Ramakrishnan R; Antonia S; Gabrilovich DI
    Cancer Immunol Immunother; 2008 Oct; 57(10):1523-9. PubMed ID: 18488219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapting conventional cancer treatment for immunotherapy.
    Qiao J; Liu Z; Fu YX
    J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining chemotherapy with biological response modifiers in treatment of cancer.
    Mitchell MS
    J Natl Cancer Inst; 1988 Nov; 80(18):1445-50. PubMed ID: 3054127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy.
    van Meir H; Kenter GG; Burggraaf J; Kroep JR; Welters MJ; Melief CJ; van der Burg SH; van Poelgeest MI
    Anticancer Agents Med Chem; 2014 Feb; 14(2):190-203. PubMed ID: 24237223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining cancer vaccines with chemotherapy.
    Chong G; Morse MA
    Expert Opin Pharmacother; 2005 Dec; 6(16):2813-20. PubMed ID: 16318432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors.
    Cheng Y; Weng S; Yu L; Zhu N; Yang M; Yuan Y
    Integr Cancer Ther; 2019; 18():1534735419876345. PubMed ID: 31522574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer immunotherapy in combination with proapoptotic therapy.
    Bruserud Ø; Ersvaer E; Olsnes A; Gjertsen BT
    Curr Cancer Drug Targets; 2008 Dec; 8(8):666-75. PubMed ID: 19075589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of correctly timing cancer immunotherapy.
    Beyranvand Nejad E; Welters MJ; Arens R; van der Burg SH
    Expert Opin Biol Ther; 2017 Jan; 17(1):87-103. PubMed ID: 27802061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinations of anticancer drugs and immunotherapy.
    Mitchell MS
    Cancer Immunol Immunother; 2003 Nov; 52(11):686-92. PubMed ID: 12942200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
    Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
    Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments.
    Pusuluri A; Wu D; Mitragotri S
    J Control Release; 2019 Jul; 305():130-154. PubMed ID: 31004668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiotherapy in the age of immunotherapy.
    Sato H; Demaria S; Ohno T
    Jpn J Clin Oncol; 2021 Apr; 51(4):513-522. PubMed ID: 33561212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity.
    Janji B; Berchem G; Chouaib S
    Front Immunol; 2018; 9():887. PubMed ID: 29922284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.